Editor’s Note: As China finishes its 14th Five-Year Plan this year, it represents a turning point. We have invited multinational CEOs to share with our readers their views on their company successes in the past few years and future goals so that we may help evaluate the success of the process.
Q1 How do you see the two sessions for this year? Do you anticipate any particular legislative actions to further deepen reforms and increase high-quality opening-up? What more should China do to make the business environment more friendly for outside investors?
Morgel: Particularly in digital transformation and sustainable development, we hope that the two sessions will continue to give policies that support economic growth and stimulate innovation top priority as China draws to an end to its 14th Five-Year Plan. China’s dedication to high-level opening-up has been encouraging; we would welcome more actions to improve the corporate climate. The industry can call for steps including improved intellectual property rights, simplified market access procedures, and more transparent regulations. Such projects will not only increase China’s appeal as a site for foreign investment but also give businesses like Lectra more chances to grow, innovate, and flourish in this active market.
Ding: As Veeva China’s general manager, I am extremely excited by the nation’s developing reforms and increasing high-level opening of the Chinese economy. Particularly in the technology and healthcare sectors, I hope the government will implement more creative support policies and enhance intellectual property rights protection to produce a more equitable, open, and predictable market environment for foreign enterprises. Furthermore, encouraging the evolution of smart and digital healthcare would open fresh growth opportunities for the pharmaceutical sector. China’s digital healthcare market already boasts a size above 100 billion yuan ($13.8 billion) and is keeping a rapid expansion trend. One unique sector pertaining to people’s health and safety is the pharmaceutical one. Encouragement of pharmaceutical companies to adopt digital technology to achieve compliant operations and efficient management in the process of drug development, production, and marketing will help the government to provide more policy support for the digital transformation and upgrading of the pharmaceutical industry, enabling more patients to have access to safe, effective, and affordable medicines faster.
Cui: As China concludes its 14th Five-Year Plan, the two sessions will highlight the high-quality development, innovation, and open economy. Unveiled to further open the economy and draw worldwide capital were recent projects including enhancing intellectual property protection for international businesses and the 2025 Action Plan for Stabilizing International Investment. Further reducing administrative processes, guaranteeing policy consistency, and enabling cross-border data flows—which will assist in building investor confidence—we are excited for more enhancements in market access and regulatory transparency. China’s continuous dedication to openness and creativity offers multinational businesses such as Aveva fresh chances to help and gain from its economic development.
TSAO: The two sessions further promote high-quality development and market-oriented reforms, which excites us since they will help create a more transparent and fair business environment for innovation. At Red Hat, we are dedicated to working with Chinese partners under open and mutually beneficial policies using open-source technology and services, thereby enabling businesses to create new productive forces and grow internationally. We can promote worldwide technical innovation and international cooperation only by more open and fair corporate policies, thereby generating more possibilities for all the stakeholders.
Second Q2 Many agree that China’s industrial upgrading and “high-quality development” would depend on “new quality productive forces.” How might your business support the development of such forces in China?
MOREL: At Lectra, we completely share China’s objective of increasing industrial output by means of “new quality productive forces.” We help it by offering cutting-edge solutions that propel the industrial revolution in important areas, including furniture, cars, and fashion. Our products enable Chinese producers to raise output in their manufacturing operations, lower material waste, and increase product quality. We help sectors fulfill more requirements by allowing more efficiency and sustainability, so we support their upgrades. We also work with nearby partners and educational institutions to build skills and encourage innovation in these important fields. By means of these projects, Lectra is eventually helping China’s industrial upgrades and high-quality development ambitions to be successful over lengthy terms.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.